SPY447.17-0.71 -0.16%
DIA348.18-0.64 -0.18%
IXIC15,181.92+20.40 0.13%

BRIEF-Novartis Receives FDA Fast Track Designation For LNA043 In Osteoarthritis Of The Knee

reuters.com · 09/02/2021 04:04
BRIEF-Novartis Receives FDA Fast Track Designation For LNA043 In Osteoarthritis Of The Knee

- Novartis AG NVS:

  • NOVARTIS RECEIVES FDA FAST TRACK DESIGNATION FOR LNA043 IN OSTEOARTHRITIS OF THE KNEE


Further company coverage: NVS


(Berlin Speed Desk)

((frankfurt.newsroom@thomsonreuters.com;))